|4Jul 19, 5:28 PM ET

Atlas Venture Fund XII, L.P. 4

4 · Aerovate Therapeutics, Inc. · Filed Jul 19, 2022

Insider Transaction Report

Form 4
Period: 2022-07-15
Transactions
  • Other

    Common Stock

    2022-07-15310,3882,327,909 total
Footnotes (1)
  • [F1]Represents a pro rata distribution, and not a purchase or sale of securities, by Atlas Venture Fund XII, L.P. ("Atlas Venture Fund XII") to its general partner and limited partners without additional consideration. This distribution was effected pursuant to a plan adopted by Atlas Venture Fund XII pursuant to Rule 10b5-1 on November 24, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION